Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Research Considerations Outcomes may vary with diet, environmental conditions, and protocol design ERR agonist effects appear to be synergistic with concurrent exercise in animal models Compound handling and capsule storage should be standardized across a study Co-administration with other ERR-active or mitochondria-targeting compounds has not been characterized Administration SLU-PP-332 in the 250 mcg capsule form is taken orally
[26] [27] It has also been successfully given intravenously to treat status epilepticus
Glycolysis then proceeds through a series of phosphorylated intermediates, starting with the synthesis of glucose-6-phosphate (Glc-6-P)
In vitro and preclinical models suggest that this supports collagen and elastin formation, antioxidant defenses, and extracellular matrix remodeling, including MMP-2 regulation, which is relevant to wound healing [4]
